|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.090 USD | -1.80% |
|
+0.93% | -62.02% |
| 06-29 | Rani Therapeutics Names Nicholas Maestas CFO | MT |
| 06-26 | Tempest Therapeutics Registers 2.43 Million Shares for Resale | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.398 | 1.86 | 3.27 |
| Spread/Res. | -22.00% | -41.40% | -66.66% |
| Spread/Supp. | +3.81% | +3.81% | +0.93% |
| Support | 1.05 | 1.05 | 1.08 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- TPST Stock
- Charts Tempest Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
